IL2RA and neoplasm: The first evidence regarding their function in inhibiting the anti-tumor immunity emerged 20 years ago, when two independent groups demonstrated that elimination of CD25+CD4+ T cells in mice is associated with enhanced anti-tumor immune responsiveness and tumor regression (126, 127).